Heart Attack News and Research

RSS

Cell-coated stent as effective as drug-coated ones

A stent that entices artery-lining cells to coat it works as well or better than drug-eluting stents in keeping arteries open in coronary heart disease patients, according to two research studies presented at the American Heart Association's Scientific Sessions 2008.

11 Nov 2008

Large trial on low-dose aspirin in diabetics

Type 2 diabetics treated with low-dose aspirin did not have a significantly lower incidence of atherosclerotic events than those who received placebo in this primary prevention trial of low-dose aspirin, according to research presented at the American Heart Association's Scientific Sessions 2008. However, sub-group analyses showed a significant reduction with aspirin in both atherosclerotic events in those over 65 years of age, and a reduction in cerebrocardiovascular deaths.

11 Nov 2008

Drug-eluting better than bare metal stents in diabetics

Drug-eluting stents reduced the risk of revascularization, heart attack and death in diabetics as compared with bare-metal stents in the largest observational comparison, researchers reported at the American Heart Association's Scientific Sessions 2008.

11 Nov 2008

Folic acid does not offer any cardiovascular benefits

Folic acid is safe - but it lacks any cardiovascular benefits - according to researchers presenting at the American Heart Association's Scientific Sessions 2008. The results from the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH), a 12,064-person, randomized study, were presented as a late-breaking clinical trial.

11 Nov 2008

Tailored anti-clotting medications reduce adverse effects after percutaneous coronary intervention

Individually tailored anti-clotting medication dosing significantly cut the rate of adverse events after non-emergent percutaneous coronary intervention (PCI) with stenting, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Stent Thrombosis study were presented as a late-breaking clinical trial.

11 Nov 2008

Timing is everything for some heart attack patients

There is strong evidence that getting to the hospital quickly during a heart attack is critical, since early treatment saves both lives and heart muscle. And if the responsible coronary artery is completely blocked, it should be opened as soon as possible.

11 Nov 2008

Rivaroxaban shows promise in patients with acute coronary syndrome

Researchers reported on a study of a new oral anti-clotting agent - rivaroxaban - designed to identify doses that would be safe to test in subsequent Phase III efficacy and safety trials. The results of ATLAS ACS-TIMI 46 were presented as a late-breaking clinical trial at the American Heart Association's Scientific Sessions 2008.

11 Nov 2008

Exercise training safe in heart failure patients - offer clinical benefit

Exercise training is safe in heart failure patients, does not significantly reduce hospitalization or death, but is associated with several improved clinical outcomes, even in those already receiving optimal medical care, researchers reported at the American Heart Association's Scientific Sessions 2008. The Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was presented as a late-breaking clinical trial.

11 Nov 2008

Public smoking ban would reduce heart attack admissions

The number of heart attack patients admitted to Michigan hospitals could be significantly reduced if a statewide public smoking ban were implemented, according to a Henry Ford Hospital study.

11 Nov 2008

Increased heart attack deaths in NYC ambulance diversions confirmed in new research

Ambulance diversions from nearby, crowded New York emergency rooms to more distant emergency departments are associated with increased deaths among patients suffering from heart attacks, according to a paper presented at a meeting of the Institute for Operations Research and the Management Sciences (INFORMS®).

11 Nov 2008

Secondary prevention program may reduce risks after heart attack

An intensive, comprehensive, long-term secondary prevention program lasting up to three years after cardiac rehabilitation appears to reduce the risk of a second non-fatal heart attack and other cardiovascular events, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

11 Nov 2008

New performance measures on performance measurement and reperfusion therapy

The ACC/AHA 2008 Task Force on Performance Measures' Statement on Performance Measurement and Reperfusion Therapy will webpost on Monday, November 10 at 2 pm ET.

11 Nov 2008

Simple blood test for high-sensitivity C-reactive protein is a useful marker for cardiovascular disease

This year, about 450,000 Americans will die of coronary heart disease – the leading cause of death for both men and women.

11 Nov 2008

Lack of sleep tied to greater risk of heart disease

Sleeping less than seven and a half hours per day may be associated with future risk of heart disease, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

11 Nov 2008

Data expands the clinical utility of deCODE tests for heart attack, atrial fibrillation and stroke

Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.

11 Nov 2008

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

VIA Pharmaceuticals, Inc. has announced the results of two Phase 2 studies of its lead drug, VIA-2291.

10 Nov 2008

Heart attack prevention within three months after hospitalization significantly averted future attacks

Despite substantial progress in the diagnosis and treatment of heart attack patients, prevention of recurrent heart attacks continues to be a major clinical challenge.

10 Nov 2008

Five key proteins form new, early-warning blood test before heart attack strikes

A team of Johns Hopkins biochemists has identified a mixed bag of five key proteins out of thousands secreted into blood draining from the heart's blood vessels that may together or in certain quantities form the basis of a far more accurate early warning test than currently in use of impending heart attack in people with severely reduced blood flow, or ischemia.

10 Nov 2008

Rising triglyceride levels may be behind rising rates of obesity

A new 30-year analysis of the National Health and Nutrition Examination Survey (NHANES) database conducted by the National Lipid Association (NLA) indicates that while Americans are doing a better job of managing LDL or "bad" cholesterol, the percentage of adults with high triglycerides, a blood fat linked to heart disease, has doubled, leaving many people at risk for potentially life-threatening events such as heart attack or stroke.

10 Nov 2008

Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes

Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA.

10 Nov 2008

Heart Attack News and Research

Cell-coated stent as effective as drug-coated ones

Large trial on low-dose aspirin in diabetics

Drug-eluting better than bare metal stents in diabetics

Folic acid does not offer any cardiovascular benefits

Tailored anti-clotting medications reduce adverse effects after percutaneous coronary intervention

Timing is everything for some heart attack patients

Rivaroxaban shows promise in patients with acute coronary syndrome

Exercise training safe in heart failure patients - offer clinical benefit

Public smoking ban would reduce heart attack admissions

Increased heart attack deaths in NYC ambulance diversions confirmed in new research

Secondary prevention program may reduce risks after heart attack

New performance measures on performance measurement and reperfusion therapy

Simple blood test for high-sensitivity C-reactive protein is a useful marker for cardiovascular disease

Lack of sleep tied to greater risk of heart disease

Data expands the clinical utility of deCODE tests for heart attack, atrial fibrillation and stroke

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

Heart attack prevention within three months after hospitalization significantly averted future attacks

Five key proteins form new, early-warning blood test before heart attack strikes

Rising triglyceride levels may be behind rising rates of obesity

Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News